Annual EBITDA
-$49.23 M
-$15.27 M-44.97%
December 31, 2021
Summary
- As of February 10, 2025, AVEO annual EBITDA is -$49.23 million, with the most recent change of -$15.27 million (-44.97%) on December 31, 2021.
- During the last 3 years, AVEO annual EBITDA has fallen by -$46.09 million (-1468.83%).
Performance
AVEO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$2.15 M
+$4.99 M+69.86%
September 30, 2022
Summary
- As of February 10, 2025, AVEO quarterly EBITDA is -$2.15 million, with the most recent change of +$4.99 million (+69.86%) on September 30, 2022.
- Over the past year, AVEO quarterly EBITDA has increased by +$7.05 million (+76.61%).
Performance
AVEO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$24.37 M
+$7.05 M+22.43%
September 30, 2022
Summary
- As of February 10, 2025, AVEO TTM EBITDA is -$24.37 million, with the most recent change of +$7.05 million (+22.43%) on September 30, 2022.
- Over the past year, AVEO TTM EBITDA has increased by +$29.75 million (+54.97%).
Performance
AVEO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AVEO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -45.0% | +76.6% | +55.0% |
| 3 y3 years | -1468.8% | -112.7% | -317.5% |
| 5 y5 years | +21.3% | +91.6% | -317.5% |
AVEO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +318.1% | at high | +102.0% |
| 5 y | 5-year | -539.4% | at low | at high | +899.3% | -317.5% | +122.1% |
| alltime | all time | -236.2% | +120.2% | -102.5% | +1422.9% | -143.3% | +359.6% |
AVEO Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$2.15 M(-69.9%) | -$24.37 M(-22.4%) |
| Jun 2022 | - | -$7.14 M(-20.6%) | -$31.41 M(-14.5%) |
| Mar 2022 | - | -$8.99 M(+47.8%) | -$36.73 M(-25.4%) |
| Dec 2021 | -$49.23 M(+45.0%) | -$6.09 M(-33.8%) | -$49.23 M(-9.0%) |
| Sep 2021 | - | -$9.20 M(-26.1%) | -$54.11 M(+2.3%) |
| Jun 2021 | - | -$12.45 M(-42.1%) | -$52.89 M(+11.6%) |
| Mar 2021 | - | -$21.49 M(+95.9%) | -$47.39 M(+39.5%) |
| Dec 2020 | -$33.96 M(-403.1%) | -$10.97 M(+37.7%) | -$33.96 M(+25.2%) |
| Sep 2020 | - | -$7.97 M(+14.6%) | -$27.12 M(+1104.6%) |
| Jun 2020 | - | -$6.95 M(-13.8%) | -$2.25 M(-211.5%) |
| Mar 2020 | - | -$8.07 M(+95.4%) | $2.02 M(-82.0%) |
| Dec 2019 | $11.20 M(-457.0%) | -$4.13 M(-124.4%) | $11.20 M(-70.3%) |
| Sep 2019 | - | $16.90 M(-729.5%) | $37.72 M(-5056.5%) |
| Jun 2019 | - | -$2.68 M(-339.9%) | -$761.00 K(-111.8%) |
| Mar 2019 | - | $1.12 M(-95.0%) | $6.48 M(-306.4%) |
| Dec 2018 | -$3.14 M(-95.0%) | $22.39 M(-203.7%) | -$3.14 M(-85.3%) |
| Sep 2018 | - | -$21.58 M(-574.1%) | -$21.39 M(-16.1%) |
| Jun 2018 | - | $4.55 M(-153.6%) | -$25.50 M(-59.4%) |
| Mar 2018 | - | -$8.49 M(-305.4%) | -$62.81 M(+0.4%) |
| Dec 2017 | -$62.55 M(+152.2%) | $4.14 M(-116.1%) | -$62.55 M(-12.8%) |
| Sep 2017 | - | -$25.69 M(-21.6%) | -$71.71 M(+42.2%) |
| Jun 2017 | - | -$32.76 M(+297.6%) | -$50.43 M(+95.4%) |
| Mar 2017 | - | -$8.24 M(+64.1%) | -$25.81 M(+4.0%) |
| Dec 2016 | -$24.81 M(+688.0%) | -$5.02 M(+13.7%) | -$24.81 M(-4.4%) |
| Sep 2016 | - | -$4.42 M(-45.7%) | -$25.95 M(+99.7%) |
| Jun 2016 | - | -$8.14 M(+12.4%) | -$12.99 M(+175.8%) |
| Mar 2016 | - | -$7.24 M(+17.4%) | -$4.71 M(+49.8%) |
| Dec 2015 | -$3.15 M | -$6.16 M(-172.1%) | -$3.15 M(-52.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $8.54 M(+5750.7%) | -$6.59 M(-76.5%) |
| Jun 2015 | - | $146.00 K(-102.6%) | -$28.05 M(-37.4%) |
| Mar 2015 | - | -$5.67 M(-41.0%) | -$44.80 M(+1.4%) |
| Dec 2014 | -$44.16 M(-55.9%) | -$9.61 M(-25.7%) | -$44.16 M(-11.1%) |
| Sep 2014 | - | -$12.92 M(-22.2%) | -$49.67 M(-16.3%) |
| Jun 2014 | - | -$16.61 M(+230.1%) | -$59.33 M(-18.5%) |
| Mar 2014 | - | -$5.03 M(-66.7%) | -$72.84 M(-27.2%) |
| Dec 2013 | -$100.13 M(-7.6%) | -$15.11 M(-33.1%) | -$100.13 M(-4.5%) |
| Sep 2013 | - | -$22.58 M(-25.0%) | -$104.85 M(-5.5%) |
| Jun 2013 | - | -$30.12 M(-6.8%) | -$110.89 M(+1.9%) |
| Mar 2013 | - | -$32.31 M(+62.9%) | -$108.84 M(+0.4%) |
| Dec 2012 | -$108.38 M(-399.9%) | -$19.83 M(-30.7%) | -$108.38 M(-3.2%) |
| Sep 2012 | - | -$28.63 M(+2.0%) | -$111.99 M(+5.6%) |
| Jun 2012 | - | -$28.07 M(-11.9%) | -$106.02 M(+28.6%) |
| Mar 2012 | - | -$31.86 M(+35.9%) | -$82.46 M(-328.2%) |
| Dec 2011 | $36.14 M(-166.9%) | -$23.44 M(+3.4%) | $36.14 M(-29.0%) |
| Sep 2011 | - | -$22.66 M(+403.4%) | $50.89 M(-9.5%) |
| Jun 2011 | - | -$4.50 M(-105.2%) | $56.25 M(+20.0%) |
| Mar 2011 | - | $86.74 M(-1098.3%) | $46.86 M(-186.7%) |
| Dec 2010 | -$54.05 M(+34.8%) | -$8.69 M(-49.8%) | -$54.05 M(-2.0%) |
| Sep 2010 | - | -$17.30 M(+24.6%) | -$55.13 M(+8.9%) |
| Jun 2010 | - | -$13.89 M(-1.9%) | -$50.63 M(+10.5%) |
| Mar 2010 | - | -$14.16 M(+45.0%) | -$45.80 M(+14.7%) |
| Dec 2009 | -$40.09 M(+37.9%) | -$9.77 M(-23.7%) | -$39.94 M(+6.0%) |
| Sep 2009 | - | -$12.80 M(+41.2%) | -$37.70 M(+51.4%) |
| Jun 2009 | - | -$9.07 M(+9.2%) | -$24.90 M(+57.3%) |
| Mar 2009 | - | -$8.30 M(+10.4%) | -$15.83 M(+110.4%) |
| Dec 2008 | -$29.07 M(+37.0%) | -$7.52 M | -$7.52 M |
| Dec 2007 | -$21.21 M | - | - |
FAQ
- What is AVEO Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for AVEO Pharmaceuticals?
- What is AVEO Pharmaceuticals annual EBITDA year-on-year change?
- What is AVEO Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for AVEO Pharmaceuticals?
- What is AVEO Pharmaceuticals quarterly EBITDA year-on-year change?
- What is AVEO Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for AVEO Pharmaceuticals?
- What is AVEO Pharmaceuticals TTM EBITDA year-on-year change?
What is AVEO Pharmaceuticals annual EBITDA?
The current annual EBITDA of AVEO is -$49.23 M
What is the all time high annual EBITDA for AVEO Pharmaceuticals?
AVEO Pharmaceuticals all-time high annual EBITDA is $36.14 M
What is AVEO Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, AVEO annual EBITDA has changed by -$15.27 M (-44.97%)
What is AVEO Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of AVEO is -$2.15 M
What is the all time high quarterly EBITDA for AVEO Pharmaceuticals?
AVEO Pharmaceuticals all-time high quarterly EBITDA is $86.74 M
What is AVEO Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, AVEO quarterly EBITDA has changed by +$7.05 M (+76.61%)
What is AVEO Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of AVEO is -$24.37 M
What is the all time high TTM EBITDA for AVEO Pharmaceuticals?
AVEO Pharmaceuticals all-time high TTM EBITDA is $56.25 M
What is AVEO Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, AVEO TTM EBITDA has changed by +$29.75 M (+54.97%)